US Bancorp DE trimmed its position in shares of Clorox Co (NYSE:CLX) by 2.8% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 162,093 shares of the company’s stock after selling 4,631 shares during the quarter. US Bancorp DE’s holdings in Clorox were worth $26,010,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of CLX. Oregon Public Employees Retirement Fund raised its position in shares of Clorox by 48,033.6% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 6,808,980 shares of the company’s stock worth $44,000 after purchasing an additional 6,794,834 shares during the period. Norges Bank acquired a new position in shares of Clorox during the fourth quarter worth approximately $175,485,000. BlackRock Inc. raised its position in shares of Clorox by 7.7% during the fourth quarter. BlackRock Inc. now owns 10,555,837 shares of the company’s stock worth $1,627,074,000 after purchasing an additional 752,085 shares during the period. Janus Henderson Group PLC raised its position in shares of Clorox by 28.4% during the first quarter. Janus Henderson Group PLC now owns 1,771,185 shares of the company’s stock worth $284,204,000 after purchasing an additional 391,569 shares during the period. Finally, Geode Capital Management LLC raised its position in shares of Clorox by 21.5% during the fourth quarter. Geode Capital Management LLC now owns 1,899,544 shares of the company’s stock worth $292,347,000 after purchasing an additional 335,835 shares during the period. 77.92% of the stock is currently owned by institutional investors.

In other Clorox news, SVP Andrew J. Mowery sold 5,340 shares of the company’s stock in a transaction on Friday, March 1st. The stock was sold at an average price of $156.44, for a total value of $835,389.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 1.40% of the stock is owned by corporate insiders.

A number of brokerages have recently weighed in on CLX. Argus lowered Clorox from a “buy” rating to a “hold” rating in a research report on Monday. BMO Capital Markets set a $168.00 target price on Clorox and gave the stock a “buy” rating in a research report on Thursday, May 2nd. Wells Fargo & Co lowered their target price on Clorox from $157.00 to $153.00 and set a “market perform” rating on the stock in a research report on Thursday, May 2nd. Bank of America reaffirmed a “neutral” rating and set a $154.00 target price (down from $165.00) on shares of Clorox in a research report on Thursday, May 2nd. Finally, Citigroup lowered their target price on Clorox from $171.00 to $160.00 and set a “neutral” rating on the stock in a research report on Thursday, May 2nd. Four investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $149.57.

NYSE CLX traded down $0.12 on Thursday, reaching $150.48. The company had a trading volume of 316,656 shares, compared to its average volume of 1,276,546. The firm has a market capitalization of $18.87 billion, a P/E ratio of 24.04, a PEG ratio of 4.31 and a beta of 0.31. The company has a current ratio of 1.10, a quick ratio of 0.66 and a debt-to-equity ratio of 2.93. Clorox Co has a 52-week low of $118.92 and a 52-week high of $167.70.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Wednesday, May 1st. The company reported $1.44 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.47 by ($0.03). The business had revenue of $1.55 billion during the quarter, compared to the consensus estimate of $1.57 billion. Clorox had a net margin of 12.68% and a return on equity of 108.82%. The firm’s revenue for the quarter was up 2.2% compared to the same quarter last year. During the same quarter last year, the company earned $1.37 EPS. As a group, sell-side analysts predict that Clorox Co will post 6.29 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 16th. Shareholders of record on Wednesday, July 31st will be paid a $1.06 dividend. This represents a $4.24 dividend on an annualized basis and a yield of 2.82%. The ex-dividend date of this dividend is Tuesday, July 30th. This is an increase from Clorox’s previous quarterly dividend of $0.96. Clorox’s dividend payout ratio is 61.34%.

COPYRIGHT VIOLATION WARNING: “US Bancorp DE Lowers Stake in Clorox Co (CLX)” was reported by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this report on another site, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The legal version of this report can be viewed at https://theolympiareport.com/2019/05/23/us-bancorp-de-lowers-stake-in-clorox-co-clx.html.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Featured Story: The role of implied volatility with call option volume

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.